Sign inGet started

Nichols Andrew John

Insider CIK 1683749 · CATB Chief Scientific Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ATXS Astria Therapeutics, Inc. A Award deriv2022-03-012022-03-0355,000— $055,000SEC↗
CATB CATABASIS PHARMACEUTICALS A Award deriv2021-06-022021-06-02600,000— $0600,000SEC↗
CATB CATABASIS PHARMACEUTICALS A Award deriv2020-02-122020-02-1460,000— $060,000SEC↗
CATB CATABASIS PHARMACEUTICALS A Award deriv2019-02-132019-02-1540,000— $040,000SEC↗
CATB CATABASIS PHARMACEUTICALS A Award deriv2018-09-072018-09-11150,000— $0150,000SEC↗
CATB CATABASIS PHARMACEUTICALS A Award deriv2018-02-082018-02-09100,000— $0100,000SEC↗
CATB CATABASIS PHARMACEUTICALS A Award deriv2017-02-092017-02-10100,000— $0100,000SEC↗
CATB CATABASIS PHARMACEUTICALS A Award deriv2016-10-032016-10-0513,000— $013,000SEC↗